Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INVO Fertility, Inc.ivob · Entity 8473 | 10% owner | December 31, 2018 | February 01, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INVO Fertility, Inc.
Report date December 31, 2018 · Filed February 01, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,344,164 |
Reported balance
After 2018-02-21 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-02-21 · Sale · Disposed 28,662 · Balance 25,344,164 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,334,164 |
Reported balance
After 2018-02-21 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2018-02-21 · Sale · Disposed 10,000 · Balance 25,334,164 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,329,164 |
Reported balance
After 2018-02-21 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2018-02-21 · Sale · Disposed 5,000 · Balance 25,329,164 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,298,864 |
Reported balance
After 2018-02-21 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2018-02-21 · Sale · Disposed 30,300 · Balance 25,298,864 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,298,764 |
Reported balance
After 2018-02-23 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2018-02-23 · Sale · Disposed 100 · Balance 25,298,764 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,296,764 |
Reported balance
After 2018-02-28 transaction · row 6
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 6 · 2018-02-28 · Sale · Disposed 2,000 · Balance 25,296,764 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,295,764 |
Reported balance
After 2018-02-21 transaction · row 7
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 7 · 2018-02-21 · Sale · Disposed 1,000 · Balance 25,295,764 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,283,122 |
Reported balance
After 2018-03-05 transaction · row 8
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 8 · 2018-03-05 · Sale · Disposed 12,642 · Balance 25,283,122 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 26,194,000 |
Reported balance
After 2018-10-31 transaction · row 9
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 9 · 2018-10-31 · Grant · Acquired 910,878 · Balance 26,194,000 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 25,194,000 |
Reported balance
After 2018-12-03 transaction · row 10
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 10 · 2018-12-03 · Other · Disposed 1,000,000 · Balance 25,194,000 |
| INVO BIOSCIENCE Common StockSEC Table I · non-derivative | Direct | 24,694,000 |
Reported balance
After 2018-12-03 transaction · row 11
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 11 · 2018-12-03 · Sale · Disposed 500,000 · Balance 24,694,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.08 | $390.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 8 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,405,751 Read SEC document |
| July 02, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 500 | $0.09 | $42.50 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 7 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,410,751 Read SEC document |
| July 02, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 30,000 | $0.08 | $2,400.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,411,251 Read SEC document |
| July 01, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 11,000 | $0.09 | $935.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,441,251 Read SEC document |
| June 28, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.10 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,452,251 Read SEC document |
| June 25, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.10 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,462,251 Read SEC document |
| January 06, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 9,222 | $0.18 | $1,659.96 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472,251 Read SEC document |
| January 05, 2010 Filed Jul 26, 2017 12:08 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.19 | $1,900.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,481,473 Read SEC document |
| December 31, 2009 Filed Jul 25, 2017 13:18 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.20 | $2,000.00 |
DisclosureSEC source: 0001511164-17-000407 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 830,000 Read SEC document |
| December 05, 2008 Filed Jul 25, 2017 13:07 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | GrantINVO Bioscience Common Stock (Restricted) | 24,661,473 | $0.00 | $19,729.18 |
DisclosureSEC source: 0001511164-17-000406 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,661,473 Read SEC document |
| December 05, 2008 Filed Jul 25, 2017 13:07 UTC | INVO Fertility, Inc. IVOB · Entity 8473 | GrantINVO Bioscience Common Stock (Free trading) | 840,000 | $0.00 | $672.00 |
DisclosureSEC source: 0001511164-17-000406 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.